News in the Life Sciences Industry

LAUSANNE, Switzerland, Oct. 9, 2019 /PRNewswire/ -- Galderma, a global leader in skin health focused on developing innovative aesthetic solutions, recently announced the Phase 2 clinical trial results for its novel ready-to-use investigational botulinum toxin, QM1114. The multicenter, randomized,... Read more ››

TOKYO, Oct. 4, 2019 /PRNewswire/ -- AI Medical Service Inc., one of the world's first real-time endoscopic artificial intelligence (AI) developers, today announced that it has raised approximately $42.9 million USD in Series B funding from Globis Capital Partners, World Innovation Lab (WiL) and... Read more ››

TOKYO, Sept. 30, 2019 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 630 million yen (US$5.9 million*) to invest in eight partnerships to develop new lifesaving drugs, vaccines and diagnostics for malaria, tuberculosis, Chagas disease and leishmaniasis.... Read more ››

LAUSANNE, Switzerland, Sept. 30, 2019 /PRNewswire/ -- Debiopharm, a Swiss-based global biopharmaceutical company, presented today, at the ESMO Congress (European Society for Medical Oncology), compelling results from a robust, randomized, Phase II study of Debio 1143 for the treatment of high-risk,... Read more ››